LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,449 | -5.2% | 1,543 | +14.1% | 0.00% | – |
Q2 2023 | $97,472 | -1.0% | 1,352 | +1.0% | 0.00% | – |
Q1 2023 | $98,488 | +6.4% | 1,339 | -2.2% | 0.00% | – |
Q4 2022 | $92,534 | -26.0% | 1,369 | -5.7% | 0.00% | – |
Q3 2022 | $125,000 | -1.6% | 1,451 | +2.1% | 0.00% | – |
Q2 2022 | $127,000 | -15.9% | 1,421 | +6.0% | 0.00% | – |
Q1 2022 | $151,000 | -18.8% | 1,341 | +10.6% | 0.00% | – |
Q4 2021 | $186,000 | +6.3% | 1,213 | -4.0% | 0.00% | – |
Q3 2021 | $175,000 | 0.0% | 1,263 | -5.7% | 0.00% | – |
Q2 2021 | $175,000 | -35.9% | 1,340 | -25.4% | 0.00% | -100.0% |
Q1 2021 | $273,000 | +15.7% | 1,796 | -23.9% | 0.00% | 0.0% |
Q4 2020 | $236,000 | -28.9% | 2,361 | -31.2% | 0.00% | 0.0% |
Q3 2020 | $332,000 | -18.4% | 3,432 | -5.7% | 0.00% | 0.0% |
Q2 2020 | $407,000 | +58.4% | 3,638 | +2.2% | 0.00% | 0.0% |
Q1 2020 | $257,000 | – | 3,561 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |